BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19881542)

  • 1. HDAC inhibitors regulate claudin-1 expression in colon cancer cells through modulation of mRNA stability.
    Krishnan M; Singh AB; Smith JJ; Sharma A; Chen X; Eschrich S; Yeatman TJ; Beauchamp RD; Dhawan P
    Oncogene; 2010 Jan; 29(2):305-12. PubMed ID: 19881542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trichostatin-A modulates claudin-1 mRNA stability through the modulation of Hu antigen R and tristetraprolin in colon cancer cells.
    Sharma A; Bhat AA; Krishnan M; Singh AB; Dhawan P
    Carcinogenesis; 2013 Nov; 34(11):2610-21. PubMed ID: 23880304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic control of HNF-4α in colon carcinoma cells affects MUC4 expression and malignancy.
    Algamas-Dimantov A; Yehuda-Shnaidman E; Peri I; Schwartz B
    Cell Oncol (Dordr); 2013 Apr; 36(2):155-67. PubMed ID: 23307400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of histone acetylation on the expression of cell cycle-associated genes in human colon cancer cell lines].
    Chen YX; Fang JY; Lu J; Qiu DK
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):312-7. PubMed ID: 15059516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells.
    Chen Z; Clark S; Birkeland M; Sung CM; Lago A; Liu R; Kirkpatrick R; Johanson K; Winkler JD; Hu E
    Cancer Lett; 2002 Dec; 188(1-2):127-40. PubMed ID: 12406558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDAC inhibitors induce epithelial-mesenchymal transition in colon carcinoma cells.
    Ji M; Lee EJ; Kim KB; Kim Y; Sung R; Lee SJ; Kim DS; Park SM
    Oncol Rep; 2015 May; 33(5):2299-308. PubMed ID: 25813246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of intestinal serotonin transporter expression via epigenetic mechanisms: role of HDAC2.
    Gill RK; Kumar A; Malhotra P; Maher D; Singh V; Dudeja PK; Alrefai W; Saksena S
    Am J Physiol Cell Physiol; 2013 Feb; 304(4):C334-41. PubMed ID: 23195070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Destabilization of ERBB2 transcripts by targeting 3' untranslated region messenger RNA associated HuR and histone deacetylase-6.
    Scott GK; Marx C; Berger CE; Saunders LR; Verdin E; Schäfer S; Jung M; Benz CC
    Mol Cancer Res; 2008 Jul; 6(7):1250-8. PubMed ID: 18644987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator.
    Pulukuri SM; Gorantla B; Rao JS
    J Biol Chem; 2007 Dec; 282(49):35594-603. PubMed ID: 17923479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines.
    Glaser KB; Staver MJ; Waring JF; Stender J; Ulrich RG; Davidsen SK
    Mol Cancer Ther; 2003 Feb; 2(2):151-63. PubMed ID: 12589032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA).
    Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O
    Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell growth inhibition and gene expression induced by the histone deacetylase inhibitor, trichostatin A, on human hepatoma cells.
    Chiba T; Yokosuka O; Fukai K; Kojima H; Tada M; Arai M; Imazeki F; Saisho H
    Oncology; 2004; 66(6):481-91. PubMed ID: 15452378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.
    Suenaga M; Soda H; Oka M; Yamaguchi A; Nakatomi K; Shiozawa K; Kawabata S; Kasai T; Yamada Y; Kamihira S; Tei C; Kohno S
    Int J Cancer; 2002 Feb; 97(5):621-5. PubMed ID: 11807787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trichostatin A, a histone deacetylase inhibitor, reverses epithelial-mesenchymal transition in colorectal cancer SW480 and prostate cancer PC3 cells.
    Wang X; Xu J; Wang H; Wu L; Yuan W; Du J; Cai S
    Biochem Biophys Res Commun; 2015 Jan; 456(1):320-6. PubMed ID: 25434997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Claudin-1 up-regulates the repressor ZEB-1 to inhibit E-cadherin expression in colon cancer cells.
    Singh AB; Sharma A; Smith JJ; Krishnan M; Chen X; Eschrich S; Washington MK; Yeatman TJ; Beauchamp RD; Dhawan P
    Gastroenterology; 2011 Dec; 141(6):2140-53. PubMed ID: 21878201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two histone deacetylase inhibitors, trichostatin A and sodium butyrate, suppress differentiation into osteoclasts but not into macrophages.
    Rahman MM; Kukita A; Kukita T; Shobuike T; Nakamura T; Kohashi O
    Blood; 2003 May; 101(9):3451-9. PubMed ID: 12511413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of histone deacetylase inhibitors Tricostatin A and Quisinostat on tight junction proteins of human lung adenocarcinoma A549 cells and normal lung epithelial cells.
    Shindo Y; Arai W; Konno T; Kohno T; Kodera Y; Chiba H; Miyajima M; Sakuma Y; Watanabe A; Kojima T
    Histochem Cell Biol; 2021 Jun; 155(6):637-653. PubMed ID: 33974136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Zebularine in Comparison to and in Combination with Trichostatin A on CIP/KIP Family (p21Cip1/Waf1/Sdi1, p27Kip1, and p57Kip2), DNMTs (DNMT1, DNMT3a, and DNMT3b), Class I HDACs (HDACs 1, 2, 3) and Class II HDACs (HDACs 4, 5, 6) Gene Expression, Cell Growth Inhibition and Apoptosis Induction in Colon Cancer LS 174T Cell Line.
    Sanaei M; Kavoosi F
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2131-2139. PubMed ID: 32711442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-invasive activity of histone deacetylase inhibitors via the induction of Egr-1 and the modulation of tight junction-related proteins in human hepatocarcinoma cells.
    Kim SO; Choi BT; Choi IW; Cheong J; Kim GY; Kwon TK; Kim ND; Choi YH
    BMB Rep; 2009 Oct; 42(10):655-60. PubMed ID: 19874710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 regulation in colon cancer cells: modulation of RNA polymerase II elongation by histone deacetylase inhibitors.
    Tong X; Yin L; Joshi S; Rosenberg DW; Giardina C
    J Biol Chem; 2005 Apr; 280(16):15503-9. PubMed ID: 15713675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.